Identification Back Directory [Name] Resibufogenin[CAS] 465-39-4 [Synonyms] rbg Respigon BUFOGENIN bufogenina RESIBUFOGENIN Resibufogeninc RESIBUFOGENIN95%,97% Resibufogenin(NSC 90783) 14,15β-Epoxy-3β-hydroxy-5β-bufa-20,22-dienolide 20,22,5BETA-BUFADIENOLID-14BETA,15BETA-EPOXY-3BETA-OL 22-dienolide,14,15-beta-epoxy-3-beta-hydroxy-5-beta-bufa-2 3-beta-hydroxy-14,15-beta-epoxy-5-beta-bufa-20,22-dienolide 14,15-beta-epoxy-3-beta-hydroxy-5-beta-bufa-20,22-dienolide 5-beta-Bufa-20,22-dienolide, 14,15-beta-epoxy-3-beta-hydroxy- (3BETA,5BETA,15BETA)-14,15EPOXY-3-HYDROXY-5-BUFA-20,22-DIENOLIDE[Molecular Formula] C24H32O4[MDL Number] MFCD00210361[MOL File] 465-39-4.mol [Molecular Weight] 384.51
Chemical Properties Back Directory [Melting point ] 113-140°/155-168°[alpha ] D22 -7.1° (c = 1.259 in chloroform); D16 -5.4° (c = 2.030 in chloroform)[Boiling point ] 431.17°C (rough estimate)[density ] 1.0474 (rough estimate)[refractive index ] 1.4860 (estimate)[storage temp. ] Inert atmosphere,2-8°C[solubility ] DMF: 25 mg/mL; DMF:PBS(pH 7.2)(1:1): 0.5 mg/mL; DMSO: 20 mg/mL; Ethanol: 5 mg/mL[form ] White to off-white solid.[pka] 15.14±0.70(Predicted)[color ] White to off-white[Stability:] Moisture Sensitive
Safety Data Back Directory [Safety Statements ] 24/25 [RIDADR ] 3172[HazardClass ] 6.1(a)[PackingGroup ] II[HS Code ] 29322090[Toxicity] LD50 oral in mouse: 59800mg/kg
Hazard Information Back Directory [Description] As one of the active components of Bufonis bufa, Resibufogenin is speculated that Etobufaxin can inhibit the proliferation of tumor cells by inducing apoptosis of osteosarcoma cells.[Uses] Resibufogenin is used for content determination/identification/pharmacological experiments, etc.[Definition] ChEBI: Bufogenin is a steroid lactone of Chan su (toad venom), a Chinese medicine obtained from the skin venom gland of toads. A specific Na/K-ATPase protein inhibitor, it is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. It has a role as an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is a steroid lactone and an epoxy steroid. It is functionally related to a bufanolide.[Biological Activity] Resibufogenin (Bufogenin, Recibufogenin) is the anticancer component of huachansu cinobufogenin, which triggers necrosis by up-regulating receptor-interacting protein kinase 3 (RIP3) and phosphorylating Ser358 of mixed lineage kinase domain-like protein. It exerts cytotoxic effects by inducing the accumulation of reactive oxygen species (ROS). Resibufogenin induces apoptosis and caspase-3 and caspase-8 activity. Also it increases Bax/Bcl-2 expression and inhibits protein expression of cyclin D1, cyclin E, PI3K, p-AKT, p-GSK3β and β-catenin.[Pharmacokinetics] The main pharmacological action of acetobufaxin is anti-tumor. The cinobufavidin injection was separated by modern chromatographic techniques, and the exobufaxin compounds were obtained. The main monomers of exobufaxin were analyzed and identified by HPLC-DAD-FT-ICR-MS. The anti-tumor activity of exobufaxin was screened in vitro, and the pancreatic cancer tumor-bearing nude mouse model was established in vivo to evaluate the efficacy of exobufaxin.[target] Target Value RIP3 () MLK () ROS () Caspase-3 () Caspase-8 () click more